<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11452">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02957851</url>
  </required_header>
  <id_info>
    <org_study_id>ALMED-15-C2-054</org_study_id>
    <nct_id>NCT02957851</nct_id>
  </id_info>
  <brief_title>EMONO for the Treatment of Peripheral Neuropathic Pain</brief_title>
  <acronym>ProtoTOP</acronym>
  <official_title>Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) for the Treatment of Peripheral Neuropathic Pain: A Randomises, International, Multicentre, Placebo-Controlled, Phenotype-stratified Phase IIa Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Air Liquide Santé International</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Advanced Medical Services GmBh - AMS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Air Liquide Santé International</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the effect of 3 consecutive days of one-hour administration of Nitrous
      Oxide/Oxygen 50%/50% (EMONO) versus placebo as Oxygen/Nitrogen 22%/78% (synthetic medical
      air), in add-on therapy to chronic analgesic treatments, on average pain intensity in
      patients with chronic peripheral neuropathic pain. A total of 250 randomised patients to be
      included in all the participating centres, i.e., 125 randomised patients in each of the 2
      study groups treatments
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>7 days after the last administration of treatment</time_frame>
    <description>Numeric Rating Scale (NRS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>28 days after the last administration of treatment</time_frame>
    <description>Numeric Rating Scale (NRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain characteristic</measure>
    <time_frame>28 days after the last administration of treatment</time_frame>
    <description>Neuropathic Pain Symptom Inventory (NPSI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life questionnaire</measure>
    <time_frame>28 days after the last administration of treatment</time_frame>
    <description>Medical Outcome Study Short Form (SF-12)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with adverse events</measure>
    <time_frame>through study duration, up to 31 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Neuralgia</condition>
  <arm_group>
    <arm_group_label>Oxygen/Nitrogen (22%/78%)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Medical Air</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nitrous Oxide/Oxygen (50%/50%)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EMONO</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Medical Air</intervention_name>
    <arm_group_label>Oxygen/Nitrogen (22%/78%)</arm_group_label>
    <other_name>Oxygen/Nitrogen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>EMONO</intervention_name>
    <arm_group_label>Nitrous Oxide/Oxygen (50%/50%)</arm_group_label>
    <other_name>Nitrous Oxide/Oxygen</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a mean pain intensity from 4 to 9 as assessed daily with a Numerating
             Rating Scale during the 7 day period preceding inclusion in spite of administration
             of usual pain treatments.

          -  Neuropathic pain lasting for more than 3 months but less than 10 years

          -  Definite or probable peripheral neuropathy

        Exclusion Criteria:

          -  legal incapacity

          -  patient with another concomitant chronic pain

          -  ongoing major depression

          -  Chemotherapy-induced peripheral neuropathic pain
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Didier Bouhassira, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Ambroise Paré Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Henry TAUPIN</last_name>
    <phone>+33 139076275</phone>
    <email>henry.taupin@airliquide.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sylvie LAROCHE, MD</last_name>
    <phone>+33 139076426</phone>
    <email>sylvie.laroche@airliquide.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <state>La Tronche</state>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline MAINDET-DOMINICI, MD</last_name>
    </contact>
    <investigator>
      <last_name>Caroline MAINDET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Bayeux</name>
      <address>
        <city>Bayeux</city>
        <zip>14401</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claire DELORME, MD</last_name>
    </contact>
    <investigator>
      <last_name>Claire DELORME, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Virginie DOUSSET, MD</last_name>
    </contact>
    <investigator>
      <last_name>Virginie DOUSSET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Ambroise Paré</name>
      <address>
        <city>Boulogne-Billancourt</city>
        <zip>92100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier BOUHASSIRA, MD</last_name>
    </contact>
    <investigator>
      <last_name>Didier BOUHASSIRA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Neurologique Weirthermer</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Bernard CAILLET, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Bernard CAILLET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Croix Rousse</name>
      <address>
        <city>Lyon</city>
        <zip>69317</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frederic AUBRUN, MD</last_name>
    </contact>
    <investigator>
      <last_name>Frederic AUBRUN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU la Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stéphanie RANQUE GARNIER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Stéphanie RANQUE GARNIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Eloi</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick GINIES, MD</last_name>
    </contact>
    <investigator>
      <last_name>Patrick GINIES, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Nord Laennec</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuelle KUHN-BOUGOUIN, MD</last_name>
    </contact>
    <investigator>
      <last_name>Emmanuelle KHUN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nouvelles Cliniques Nantaises</name>
      <address>
        <city>Nantes</city>
        <zip>44202</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thibault RIANT, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Universitaire Caremeau</name>
      <address>
        <city>Nimes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric VIEL, MD</last_name>
    </contact>
    <investigator>
      <last_name>Eric VIEL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Lariboisière</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain SERRIE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Alain SERRIE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Serge PERROT, MD</last_name>
    </contact>
    <investigator>
      <last_name>Serge PERROT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neurologische Klinik Universitätsklinikum</name>
      <address>
        <city>Würzburg</city>
        <state>Josef-Schneider-Str. 11</state>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claudia SOMMER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Claudia SOMMER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neurologische Klinik Klinikum rechts der Isar</name>
      <address>
        <city>Munchen</city>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas TOLLE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Thomas TOLLE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 6, 2016</lastchanged_date>
  <firstreceived_date>October 20, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nitrous Oxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
